Postprandial lipoprotein metabolism: VLDL vs chylomicrons
- PMID: 21531214
- PMCID: PMC3265327
- DOI: 10.1016/j.cca.2011.04.018
Postprandial lipoprotein metabolism: VLDL vs chylomicrons
Abstract
Since Zilversmit first proposed postprandial lipemia as the most common risk of cardiovascular disease, chylomicrons (CM) and CM remnants have been thought to be the major lipoproteins which are increased in the postprandial hyperlipidemia. However, it has been shown over the last two decades that the major increase in the postprandial lipoproteins after food intake occurs in the very low density lipoprotein (VLDL) remnants (apoB-100 particles), not CM or CM remnants (apoB-48 particles). This finding was obtained using the following three analytical methods; isolation of remnant-like lipoprotein particles (RLP) with specific antibodies, separation and detection of lipoprotein subclasses by gel permeation HPLC and determination of apoB-48 in fractionated lipoproteins by a specific ELISA. The amount of the apoB-48 particles in the postprandial RLP is significantly less than the apoB-100 particles, and the particle sizes of apoB-48 and apoB-100 in RLP are very similar when analyzed by HPLC. Moreover, CM or CM remnants having a large amount of TG were not found in the postprandial RLP. Therefore, the major portion of the TG which is increased in the postprandial state is composed of VLDL remnants, which have been recognized as a significant risk for cardiovascular disease.
Copyright © 2011 Elsevier B.V. All rights reserved.
Figures







Similar articles
-
Postprandial remnant-like lipoproteins in hypertriglyceridemia.J Clin Endocrinol Metab. 2001 Jul;86(7):3134-42. doi: 10.1210/jcem.86.7.7627. J Clin Endocrinol Metab. 2001. PMID: 11443178
-
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.Clin Chim Acta. 2018 Mar;478:200-215. doi: 10.1016/j.cca.2017.12.039. Epub 2018 Jan 4. Clin Chim Acta. 2018. PMID: 29307667 Review.
-
Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.J Lipid Res. 1998 Jul;39(7):1412-20. J Lipid Res. 1998. PMID: 9684744
-
The VLDL receptor plays a key role in the metabolism of postprandial remnant lipoproteins.Clin Chim Acta. 2019 Aug;495:382-393. doi: 10.1016/j.cca.2019.05.004. Epub 2019 May 10. Clin Chim Acta. 2019. PMID: 31078566
-
Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis.Curr Opin Endocrinol Diabetes Obes. 2018 Apr;25(2):108-117. doi: 10.1097/MED.0000000000000393. Curr Opin Endocrinol Diabetes Obes. 2018. PMID: 29493553 Review.
Cited by
-
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism.Curr Atheroscler Rep. 2023 Mar;25(3):67-76. doi: 10.1007/s11883-023-01080-8. Epub 2023 Jan 23. Curr Atheroscler Rep. 2023. PMID: 36689070 Free PMC article. Review.
-
In vivo monitoring of hepatic glycolipid distribution of n-6 ∕ n-3 in jugular-vein-cannulated rats as a nutritional research model for monogastric animal.Arch Anim Breed. 2019 Jul 19;62(2):437-446. doi: 10.5194/aab-62-437-2019. eCollection 2019. Arch Anim Breed. 2019. PMID: 31807655 Free PMC article.
-
Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.J Clin Lipidol. 2020 Mar-Apr;14(2):241-251. doi: 10.1016/j.jacl.2020.02.005. Epub 2020 Feb 21. J Clin Lipidol. 2020. PMID: 32205068 Free PMC article.
-
Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis.Mol Metab. 2018 May;11:59-69. doi: 10.1016/j.molmet.2018.03.011. Epub 2018 Mar 29. Mol Metab. 2018. PMID: 29627378 Free PMC article.
-
NMR derived changes of lipoprotein particle concentrations related to impaired fasting glucose, impaired glucose tolerance, or manifest type 2 diabetes mellitus.Lipids Health Dis. 2023 Mar 24;22(1):42. doi: 10.1186/s12944-023-01801-7. Lipids Health Dis. 2023. PMID: 36964528 Free PMC article.
References
-
- Havel RJ. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol. 1994;5:102–9. - PubMed
-
- Havel RJ. Remnant lipoproteins as therapeutic targets. Curr Opin Lipidol. 2000;11:615–20. - PubMed
-
- Iso H, Naito Y, Sato S, et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol. 2001;153:490–9. - PubMed
-
- Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299–308. - PubMed
-
- Bansal S, Buring J, Rifai N, Mora S, Sacks FM, Rider PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309–16. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous